UG

Usman Gani

Active Director Director DIN 08351351
DIN 08351351 First appointment Feb 2019 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Feb 2019
Shareholding value Locked Premium profile

About Usman Gani

Usman Gani has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Usz Remedium Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08351351
Primary Designation Director
First Appointment 04 Feb 2019
Oldest Company Age 7 yrs

Current companies

Company Designation Appointment Founded Status
Usz Remedium Private Limited U36900JK2019PTC010819
Director 04 Feb 2019 2019 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Usz Remedium Private Limited
Premium access

Shareholding and investment profile for Usman Gani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Usman Gani

Usman Gani has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Usz Remedium Private Limited. Engaged in General Business. Contributes to corporate operations.

Usman Gani is associated with 1 company as Director.

Usman Gani has expertise in General Business.

Usman Gani has 7 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available